• HyperFluor™ 488 for Vaccine Assay Decisions

  2026-09-08

  Discover how the HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody can connect vaccine-design questions with reproducible serological, cellular, and tissue-based readouts. This guide translates findings from a broad-spectrum SARS-CoV-2 vaccine study into practical secondary-antibody decisions and assay controls.

• Purmorphamine Workflows for Smoothened Signaling

  2026-09-08

  Purmorphamine is a practical Smoothened agonist for connecting Hedgehog pathway activation with osteogenic, neural, and insect sensory readouts. This workflow-led guide covers dose planning, cross-species interpretation, assay design, and troubleshooting for more reproducible experiments.

• Tubastatin A in Post-Resuscitation Myocardial Injury

  2026-09-07

  A porcine cardiac-arrest study found that Tubastatin A reduced post-resuscitation myocardial dysfunction, cardiac injury biomarkers, and molecular signatures associated with GSDME-mediated pyroptosis and MLKL-mediated necroptosis. The work is important because it connects selective HDAC6 inhibition with convergent regulated cell-death pathways in a clinically relevant large-animal model, while still requiring mechanistic and translational validation.

• PreScission Protease for dKeap1 Condensate Studies

  2026-09-07

  PreScission Protease enables controlled removal of affinity and fluorescent tags from dKeap1 constructs, helping researchers distinguish intrinsic condensate behavior from tag-driven artifacts. Its site-specific HRV 3C protease activity and low-temperature workflow are well suited to fragile proteins and structure-sensitive phase-separation assays.

• MEK/ERK, c-Myc, and TERT Polycomb Control

  2026-09-05

  This preprint identifies a regulatory pathway in human pluripotent stem cells in which MEK/ERK signaling and c-Myc:MAX limit PRC2-associated repression at the TERT promoter. Its combination of kinase perturbation, chromatin profiling, and rescue experiments links signaling state to telomerase transcription while also defining important limits for translating the findings to cancer models.

• Female LUAD Biomarkers: FOXM1 and ERα Networks

  2026-09-04

  This reference study integrates transcriptomic, survival, immune, and ceRNA analyses to investigate FOXM1 in female lung adenocarcinoma. Its most useful contribution is a testable link among FOXM1, miR-204-5p, and estrogen receptor signaling, although the proposed network remains only partially validated and requires further mechanistic study.

• Acetoacetic Acid Sodium Salt: Metabolic Workflows

  2026-09-04

  Build reproducible ketone-body experiments with a water-compatible substrate for energy metabolism research, diabetes metabolic imbalance models, and biomarker assay development. This guide combines practical preparation, quantitative workflow design, reference-study insights, and troubleshooting for more defensible results.

• Epigenetic Immune Signatures in Melanoma

  2026-09-03

  Anichini et al. compared multiple epigenetic drug classes in melanoma and showed that guadecitabine produced the strongest and most consistent immune-related transcriptional program. The study links this DNMT inhibitor signature to innate immune regulators, patient biopsy responses, and improved prognostic associations, while also defining why epigenetic agents should not be treated as interchangeable immunotherapy partners.

• Caspase-4 Colorimetric Assay Kit Workflow

  2026-09-03

  Build a quantitative LEVD-dependent caspase-4 workflow for pyroptosis, inflammasome, and inflammatory signaling studies. This guide also shows how the assay can complement ER-targeted peptide self-assembly research without confusing caspase activity with proof of a specific cell-death mechanism.

• Oseltamivir acid: Applied Research Workflows

  2026-09-02

  Oseltamivir acid supports mechanism-led influenza antiviral research, resistance testing, and exploratory oncology studies. This guide translates its neuraminidase biology into practical assay workflows, human-relevant exposure questions, and troubleshooting strategies.

• Rencofilstat–Ixazomib in Advanced Prostate Cancer

  2026-09-02

  A 2025 Biomedicines study shows that combining the pan-cyclophilin inhibitor rencofilstat with the proteasome inhibitor ixazomib intensifies proteotoxic stress and apoptotic death in advanced prostate cancer cells while sparing non-cancer cells. Its mechanistic contribution is the identification of altered XBP1s, PERK, cyclophilin, CD147, and ERK signaling as interconnected determinants of treatment response.

• Fenipentol: From Natural Product to Assay Design

  2026-09-01

  Fenipentol, also known as 1-Phenyl-1-pentanol, connects a Ligusticum chuanxiong natural-product signal with testable gastrointestinal, hepatobiliary, and cardiovascular hypotheses. This article focuses on evidence hierarchy, assay selection, and practical workflow decisions rather than repeating a conventional mechanism overview.

• HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody

  2026-09-01

  A scenario-driven guide to using HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody, SKU K1214, in immunofluorescence, flow cytometry, Western blotting, and tissue staining workflows. It explains how to improve detection of goat primary antibodies while separating fluorescence-based mechanistic readouts from direct cell-viability measurements.

• Persistent rDNA Damage and PML-Nucleolar Compartments

  2026-08-31

  Urbancokova, Hornofova and colleagues identify persistent ribosomal DNA damage as a specific trigger of PML-nucleolar associations, linking topological stress, RNA polymerase I inhibition, and incomplete homologous recombination. The study provides a useful framework for distinguishing transient genotoxic stress from lesions that reorganize nucleolar architecture and promote senescence.

• HRP Secondary Antibodies in Plastic Toxicology

  2026-08-31

  A translational perspective on how HRP-based immunodetection can strengthen mechanistic studies of microplastic- and nanoplastic-induced pulmonary fibrosis, with practical guidance for deploying goat primary antibodies across toxicology workflows.

8507 records 1/568 page Next 12345 下5页 Last page